| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
69,868 |
63,766 |
$6.38M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
53,541 |
46,677 |
$4.32M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,443 |
6,649 |
$1.36M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
13,819 |
12,797 |
$1.32M |
| 80053 |
Comprehensive metabolic panel |
40,300 |
31,816 |
$854K |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,278 |
7,017 |
$844K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,163 |
9,057 |
$629K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,007 |
2,597 |
$546K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,522 |
3,085 |
$502K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,881 |
10,467 |
$323K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,993 |
2,834 |
$317K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,139 |
2,695 |
$302K |
| 59025 |
Fetal non-stress test |
5,189 |
4,024 |
$256K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19,457 |
17,379 |
$232K |
| A9270 |
Non-covered item or service |
26,051 |
4,992 |
$164K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,048 |
758 |
$164K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,126 |
2,656 |
$138K |
| 72131 |
|
2,495 |
2,190 |
$128K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,918 |
1,692 |
$114K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,330 |
1,121 |
$113K |
| G0378 |
Hospital observation service, per hour |
13,176 |
6,807 |
$109K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,319 |
3,344 |
$102K |
| 86850 |
|
2,972 |
2,487 |
$96K |
| 81003 |
|
33,955 |
29,440 |
$91K |
| 87070 |
|
8,492 |
7,939 |
$83K |
| 85027 |
|
56,403 |
42,343 |
$78K |
| 84702 |
|
4,523 |
3,689 |
$75K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,316 |
1,236 |
$74K |
| 36415 |
Collection of venous blood by venipuncture |
3,578 |
2,819 |
$73K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,179 |
1,777 |
$71K |
| 70496 |
|
408 |
348 |
$66K |
| 58661 |
|
41 |
37 |
$66K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
4,196 |
3,873 |
$56K |
| 93976 |
|
4,305 |
3,831 |
$56K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,325 |
4,030 |
$55K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
390 |
317 |
$55K |
| 86403 |
|
3,781 |
3,614 |
$52K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
342 |
316 |
$50K |
| 76830 |
Ultrasound, transvaginal |
4,252 |
3,732 |
$49K |
| 10060 |
|
880 |
812 |
$45K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,621 |
1,287 |
$44K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,605 |
18,188 |
$42K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,042 |
974 |
$38K |
| 71045 |
Radiologic examination, chest; single view |
15,432 |
12,824 |
$37K |
| 73610 |
|
1,672 |
1,553 |
$37K |
| 81025 |
|
13,037 |
11,830 |
$34K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,934 |
1,757 |
$33K |
| 71046 |
Radiologic examination, chest; 2 views |
6,289 |
5,529 |
$33K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20,283 |
15,283 |
$31K |
| 12001 |
|
486 |
459 |
$31K |
| 87449 |
|
2,284 |
2,075 |
$31K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,308 |
2,520 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,641 |
5,833 |
$30K |
| 73130 |
|
1,588 |
1,462 |
$30K |
| 73562 |
|
1,830 |
1,609 |
$28K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,239 |
761 |
$28K |
| 73630 |
|
1,929 |
1,767 |
$27K |
| 84484 |
|
17,447 |
11,520 |
$27K |
| 85014 |
|
442 |
351 |
$27K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,998 |
8,033 |
$26K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,322 |
1,493 |
$25K |
| J1644 |
Injection, heparin sodium, per 1000 units |
6,919 |
3,221 |
$25K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,494 |
3,840 |
$25K |
| 72128 |
|
298 |
268 |
$24K |
| 84703 |
|
5,373 |
4,877 |
$24K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,689 |
1,376 |
$24K |
| 73030 |
|
1,596 |
1,382 |
$23K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
18,834 |
15,956 |
$22K |
| 71250 |
|
470 |
372 |
$20K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,488 |
4,824 |
$19K |
| C1769 |
Guide wire |
1,644 |
1,247 |
$18K |
| 73110 |
|
914 |
842 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,690 |
5,292 |
$16K |
| 87040 |
|
5,487 |
3,534 |
$16K |
| 86900 |
|
4,010 |
3,405 |
$16K |
| 85610 |
|
8,326 |
6,642 |
$16K |
| 87077 |
|
3,160 |
2,695 |
$15K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
671 |
614 |
$15K |
| 93971 |
|
1,608 |
1,411 |
$14K |
| 83690 |
|
13,006 |
11,134 |
$14K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
27 |
27 |
$14K |
| 82550 |
|
4,264 |
2,751 |
$14K |
| 83735 |
|
13,052 |
9,396 |
$14K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,241 |
3,247 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
363 |
299 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,285 |
7,680 |
$10K |
| 12011 |
|
183 |
173 |
$10K |
| 12002 |
|
202 |
191 |
$10K |
| 70486 |
|
397 |
351 |
$10K |
| 85730 |
|
6,795 |
5,500 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
1,473 |
1,055 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,296 |
7,143 |
$9K |
| 83880 |
|
4,811 |
3,948 |
$9K |
| 93970 |
|
855 |
758 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,629 |
3,390 |
$8K |
| 84112 |
|
157 |
141 |
$8K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
923 |
718 |
$8K |
| 93017 |
|
512 |
415 |
$8K |
| 73080 |
|
602 |
529 |
$8K |
| 70491 |
|
42 |
36 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,504 |
1,022 |
$7K |
| 76770 |
|
175 |
162 |
$7K |
| 76937 |
|
457 |
352 |
$7K |
| J1815 |
Injection, insulin, per 5 units |
2,667 |
1,177 |
$7K |
| 80061 |
Lipid panel |
2,814 |
2,207 |
$7K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,541 |
1,213 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
90 |
83 |
$5K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
283 |
128 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,119 |
3,328 |
$5K |
| 82553 |
|
1,950 |
1,392 |
$5K |
| 83605 |
|
5,037 |
3,959 |
$5K |
| 87205 |
|
1,176 |
919 |
$5K |
| 73140 |
|
290 |
274 |
$5K |
| 73590 |
|
333 |
304 |
$5K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
115 |
91 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,373 |
1,601 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,854 |
7,081 |
$4K |
| 72100 |
|
515 |
472 |
$4K |
| 84100 |
|
3,169 |
2,213 |
$4K |
| 70498 |
|
376 |
317 |
$4K |
| 87186 |
|
2,639 |
2,256 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,529 |
4,261 |
$4K |
| 85379 |
|
2,576 |
2,243 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
14,730 |
13,726 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,543 |
1,231 |
$3K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
28 |
24 |
$3K |
| 90715 |
|
1,215 |
1,086 |
$3K |
| 00840 |
|
248 |
214 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,419 |
2,463 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,342 |
1,862 |
$3K |
| 82731 |
|
13 |
12 |
$3K |
| 74018 |
|
465 |
416 |
$3K |
| 82607 |
|
1,507 |
1,206 |
$3K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
139 |
114 |
$3K |
| 86901 |
|
3,894 |
3,298 |
$3K |
| 80076 |
|
3,435 |
3,079 |
$3K |
| 73502 |
|
357 |
306 |
$3K |
| 83986 |
|
135 |
123 |
$3K |
| 97161 |
|
181 |
139 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,520 |
2,945 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
877 |
692 |
$2K |
| 73090 |
|
210 |
198 |
$2K |
| J7999 |
Compounded drug, not otherwise classified |
81 |
62 |
$2K |
| 87807 |
|
1,600 |
1,541 |
$2K |
| 80047 |
|
29 |
26 |
$2K |
| 64400 |
|
13 |
13 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
71 |
45 |
$1K |
| 76641 |
|
29 |
28 |
$1K |
| 86140 |
|
1,017 |
897 |
$1K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
50 |
41 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
449 |
374 |
$1K |
| 84439 |
|
1,483 |
1,197 |
$1K |
| 82248 |
|
1,706 |
1,219 |
$1K |
| 82077 |
|
588 |
501 |
$1K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
247 |
182 |
$1K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
49 |
41 |
$932.82 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
537 |
417 |
$930.05 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,669 |
2,056 |
$888.42 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,728 |
1,994 |
$875.61 |
| 97116 |
|
267 |
190 |
$870.94 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
996 |
765 |
$867.54 |
| 97535 |
Self-care/home management training, each 15 minutes |
447 |
274 |
$832.94 |
| 83540 |
|
377 |
312 |
$806.95 |
| 82728 |
|
251 |
211 |
$750.81 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
791 |
670 |
$705.68 |
| 82570 |
|
660 |
566 |
$659.15 |
| 83550 |
|
260 |
218 |
$649.66 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
257 |
174 |
$640.46 |
| J2060 |
Injection, lorazepam, 2 mg |
1,025 |
763 |
$587.83 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
291 |
234 |
$575.77 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
17 |
15 |
$570.52 |
| 82565 |
|
31 |
26 |
$568.86 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
2,239 |
2,052 |
$478.21 |
| 82803 |
|
105 |
83 |
$457.16 |
| 97162 |
|
68 |
53 |
$431.86 |
| 80320 |
|
121 |
98 |
$429.60 |
| 72072 |
|
29 |
25 |
$402.81 |
| 84156 |
|
559 |
467 |
$388.91 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
173 |
123 |
$367.77 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
170 |
159 |
$293.35 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
448 |
293 |
$262.16 |
| J3490 |
Unclassified drugs |
182 |
151 |
$244.21 |
| 85651 |
|
429 |
364 |
$220.01 |
| 87400 |
|
2,080 |
1,927 |
$210.92 |
| 72040 |
|
30 |
24 |
$210.81 |
| 85520 |
|
788 |
602 |
$209.62 |
| 88302 |
|
30 |
26 |
$191.70 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
299 |
236 |
$190.39 |
| 88304 |
|
116 |
100 |
$158.45 |
| 72170 |
|
15 |
13 |
$152.69 |
| 73552 |
|
33 |
28 |
$152.69 |
| 29125 |
|
143 |
133 |
$146.17 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,272 |
1,063 |
$138.02 |
| 76818 |
|
12 |
12 |
$135.83 |
| 88307 |
|
60 |
51 |
$126.07 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
699 |
462 |
$122.02 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,628 |
3,389 |
$118.18 |
| 90662 |
|
187 |
144 |
$115.61 |
| J1940 |
Injection, furosemide, up to 20 mg |
76 |
38 |
$113.13 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
565 |
483 |
$112.90 |
| 82746 |
|
293 |
247 |
$91.41 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
464 |
313 |
$90.00 |
| G0008 |
Administration of influenza virus vaccine |
272 |
208 |
$87.24 |
| 84550 |
|
172 |
148 |
$63.55 |
| 87430 |
|
729 |
699 |
$44.51 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
140 |
100 |
$38.48 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
68 |
68 |
$33.65 |
| 87081 |
|
14 |
13 |
$23.01 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
484 |
272 |
$15.00 |
| 82140 |
|
78 |
51 |
$6.68 |
| 73660 |
|
12 |
12 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
30 |
26 |
$0.00 |
| 96376 |
|
584 |
478 |
$0.00 |
| 87147 |
|
41 |
41 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
78 |
63 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
26 |
25 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
44 |
41 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
144 |
132 |
$0.00 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
150 |
137 |
$0.00 |
| 97166 |
|
19 |
12 |
$0.00 |
| 82330 |
|
41 |
34 |
$0.00 |
| 82150 |
|
16 |
12 |
$0.00 |
| 87340 |
|
14 |
12 |
$0.00 |
| 83615 |
|
16 |
14 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
15 |
12 |
$0.00 |
| 90686 |
|
16 |
13 |
$0.00 |
| 85384 |
|
77 |
69 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
849 |
706 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
331 |
190 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
12 |
12 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
134 |
125 |
$0.00 |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
18 |
13 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
88 |
67 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
55 |
36 |
$0.00 |
| 82009 |
|
63 |
49 |
$0.00 |
| C1758 |
Catheter, ureteral |
16 |
13 |
$0.00 |
| 99152 |
|
29 |
25 |
$0.00 |